AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$AXON

Kalinowski Caitlin Elizabeth sold $19K of AXON

Kalinowski Caitlin Elizabeth sold 40 shares of AXON ENTERPRISE, INC. (AXON) at $480.55 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

This provides a fresh, timestamped datapoint on director ownership but does not introduce new operational or financial guidance.

02

Market read

Traders may monitor for follow-on insider activity, but absent other catalysts the expected market impact is limited.

03

What to watch

The sale is small relative to typical liquidity/float and the filing does not provide rationale, so signal-to-noise is low without corroborating news.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed after-hours (2026-06-02) for a sale dated 2026-06-01

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon director Caitlin Elizabeth Kalinowski sold 40 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Low probability of a sustained price move; any reaction is likely short-lived unless accompanied by broader company news.

Evidence & confidence

The filing provides a specific sale size/price and notes no 10b5-1 plan, but it does not disclose earnings, guidance, or operational developments.

Market effects

Sector

Minimal—this is company-specific insider activity without sector-wide information.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

A non-10b5-1 sale can be misread as bearish; it may simply reflect personal liquidity needs and not a view on Axon fundamentals.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Subject of the insider transaction disclosure (director sale).

  • insider
    Caitlin Elizabeth Kalinowski

    Director who sold 40 shares at $480.55 on 2026-06-01; filing made 2026-06-02.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

AUG 23
$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

tikr.com3 min
AUG 20
$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

fool.com4 min
AUG 10
$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

finance.yahoo.com4 min
AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min